Design and accrual of S1417CD: Development of a prospective financial impact assessment tool in patients with metastatic colorectal cancer (mCRC). Article
Full Text via DOI: 10.1200/JCO.2019.37.15_suppl.TPS6652
Web of Science: 000487345803420